ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tumor NGS Genetic Testing Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-4Y13821
Home | Market Reports | Science| Biological Sciences
Global Tumor NGS Genetic Testing Market Research Report 2023
BUY CHAPTERS

Global Tumor NGS Genetic Testing Market Research Report 2025

Code: QYRE-Auto-4Y13821
Report
May 2025
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Foundation Medicine
Guardant Health
Illumina Inc
Thermo Fisher Scientific Inc
Dian Diagnostics Group Co.,Ltd.
Burning Rock Biotech
NovogeneCo.,Ltd.
Amoy Diagnostics Co.,Ltd.
China National Pharmaceutical Group Corporation
Shanghai Fosun Pharmaceutical (Group) Co. Ltd.
Guangzhou Kingmed Diagnostics Group Co., Ltd.
Adicon Clinical Laboratories Inc.
Genetron
BGI Genomics Co.,Ltd.
Haplox
Nanjing Shihejiyin Technology, Inc.
Genecast Group Inc.
Beijing-Geneplus Technology Limited.
Xiamen SpacegenCo., Ltd.
Geneis（Beijing）Co.Ltd.

Tumor NGS Genetic Testing Market

The global market for Tumor NGS Genetic Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Tumor NGS Genetic Testing is to use high-throughput sequencing to understand tumors at the genetic level, detect and quantify the genetic components that drive tumors.
North American market for Tumor NGS Genetic Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Tumor NGS Genetic Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Tumor NGS Genetic Testing in Companion Diagnostics is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Tumor NGS Genetic Testing include Foundation Medicine, Guardant Health, Illumina, Thermo Fisher Scientific Inc., DIAN DIAGNOSTICS Group Co., Ltd., Burning Rock Biotech., NovogeneCo.,Ltd., Nanjing Shihejiyin Technology, Inc., Amoy Diagnostics Co.,Ltd., China National Pharmaceutical Group Corporation, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Tumor NGS Genetic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor NGS Genetic Testing.
The Tumor NGS Genetic Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tumor NGS Genetic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tumor NGS Genetic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Tumor NGS Genetic Testing Market Report

Report Metric Details
Report Name Tumor NGS Genetic Testing Market
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Foundation Medicine, Guardant Health, Illumina, Thermo Fisher Scientific Inc., DIAN DIAGNOSTICS Group Co., Ltd., Burning Rock Biotech., NovogeneCo.,Ltd., Nanjing Shihejiyin Technology, Inc., Amoy Diagnostics Co.,Ltd., China National Pharmaceutical Group Corporation, Shanghai Fosun Pharmaceutical(Group)Co.,Ltd., Guangzhou Kingmed Diagnostics Group Co.,Ltd., ADICON Clinical Laboratories, Inc., Genetron, Genecast Group Inc., BGI Genomics Co.,Ltd., Beijing-Geneplus Technology Limited., Xiamen SpacegenCo., Ltd., Geneis（Beijing）Co.Ltd., HaploX
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Tumor NGS Genetic Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Tumor NGS Genetic Testing Market report?

Ans: The main players in the Tumor NGS Genetic Testing Market are Foundation Medicine, Guardant Health, Illumina, Thermo Fisher Scientific Inc., DIAN DIAGNOSTICS Group Co., Ltd., Burning Rock Biotech., NovogeneCo.,Ltd., Nanjing Shihejiyin Technology, Inc., Amoy Diagnostics Co.,Ltd., China National Pharmaceutical Group Corporation, Shanghai Fosun Pharmaceutical(Group)Co.,Ltd., Guangzhou Kingmed Diagnostics Group Co.,Ltd., ADICON Clinical Laboratories, Inc., Genetron, Genecast Group Inc., BGI Genomics Co.,Ltd., Beijing-Geneplus Technology Limited., Xiamen SpacegenCo., Ltd., Geneis（Beijing）Co.Ltd., HaploX

What are the Application segmentation covered in the Tumor NGS Genetic Testing Market report?

Ans: The Applications covered in the Tumor NGS Genetic Testing Market report are Companion Diagnostics, Early Cancer Screening, Drug Discovery

What are the Type segmentation covered in the Tumor NGS Genetic Testing Market report?

Ans: The Types covered in the Tumor NGS Genetic Testing Market report are Liquid Biopsy (Blood Sample), Tissue Biopsy

Recommended Reports

Cancer Diagnostics

Genetic Testing

NGS Applications

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor NGS Genetic Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Liquid Biopsy (Blood Sample)
1.2.3 Tissue Biopsy
1.3 Market by Application
1.3.1 Global Tumor NGS Genetic Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Companion Diagnostics
1.3.3 Early Cancer Screening
1.3.4 Drug Discovery
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tumor NGS Genetic Testing Market Perspective (2020-2031)
2.2 Global Tumor NGS Genetic Testing Growth Trends by Region
2.2.1 Global Tumor NGS Genetic Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Tumor NGS Genetic Testing Historic Market Size by Region (2020-2025)
2.2.3 Tumor NGS Genetic Testing Forecasted Market Size by Region (2026-2031)
2.3 Tumor NGS Genetic Testing Market Dynamics
2.3.1 Tumor NGS Genetic Testing Industry Trends
2.3.2 Tumor NGS Genetic Testing Market Drivers
2.3.3 Tumor NGS Genetic Testing Market Challenges
2.3.4 Tumor NGS Genetic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tumor NGS Genetic Testing Players by Revenue
3.1.1 Global Top Tumor NGS Genetic Testing Players by Revenue (2020-2025)
3.1.2 Global Tumor NGS Genetic Testing Revenue Market Share by Players (2020-2025)
3.2 Global Tumor NGS Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Tumor NGS Genetic Testing Revenue
3.4 Global Tumor NGS Genetic Testing Market Concentration Ratio
3.4.1 Global Tumor NGS Genetic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor NGS Genetic Testing Revenue in 2024
3.5 Global Key Players of Tumor NGS Genetic Testing Head office and Area Served
3.6 Global Key Players of Tumor NGS Genetic Testing, Product and Application
3.7 Global Key Players of Tumor NGS Genetic Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Tumor NGS Genetic Testing Breakdown Data by Type
4.1 Global Tumor NGS Genetic Testing Historic Market Size by Type (2020-2025)
4.2 Global Tumor NGS Genetic Testing Forecasted Market Size by Type (2026-2031)
5 Tumor NGS Genetic Testing Breakdown Data by Application
5.1 Global Tumor NGS Genetic Testing Historic Market Size by Application (2020-2025)
5.2 Global Tumor NGS Genetic Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Tumor NGS Genetic Testing Market Size (2020-2031)
6.2 North America Tumor NGS Genetic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Tumor NGS Genetic Testing Market Size by Country (2020-2025)
6.4 North America Tumor NGS Genetic Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tumor NGS Genetic Testing Market Size (2020-2031)
7.2 Europe Tumor NGS Genetic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Tumor NGS Genetic Testing Market Size by Country (2020-2025)
7.4 Europe Tumor NGS Genetic Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tumor NGS Genetic Testing Market Size (2020-2031)
8.2 Asia-Pacific Tumor NGS Genetic Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Tumor NGS Genetic Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Tumor NGS Genetic Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tumor NGS Genetic Testing Market Size (2020-2031)
9.2 Latin America Tumor NGS Genetic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Tumor NGS Genetic Testing Market Size by Country (2020-2025)
9.4 Latin America Tumor NGS Genetic Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tumor NGS Genetic Testing Market Size (2020-2031)
10.2 Middle East & Africa Tumor NGS Genetic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Tumor NGS Genetic Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Tumor NGS Genetic Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Foundation Medicine
11.1.1 Foundation Medicine Company Details
11.1.2 Foundation Medicine Business Overview
11.1.3 Foundation Medicine Tumor NGS Genetic Testing Introduction
11.1.4 Foundation Medicine Revenue in Tumor NGS Genetic Testing Business (2020-2025)
11.1.5 Foundation Medicine Recent Development
11.2 Guardant Health
11.2.1 Guardant Health Company Details
11.2.2 Guardant Health Business Overview
11.2.3 Guardant Health Tumor NGS Genetic Testing Introduction
11.2.4 Guardant Health Revenue in Tumor NGS Genetic Testing Business (2020-2025)
11.2.5 Guardant Health Recent Development
11.3 Illumina
11.3.1 Illumina Company Details
11.3.2 Illumina Business Overview
11.3.3 Illumina Tumor NGS Genetic Testing Introduction
11.3.4 Illumina Revenue in Tumor NGS Genetic Testing Business (2020-2025)
11.3.5 Illumina Recent Development
11.4 Thermo Fisher Scientific Inc.
11.4.1 Thermo Fisher Scientific Inc. Company Details
11.4.2 Thermo Fisher Scientific Inc. Business Overview
11.4.3 Thermo Fisher Scientific Inc. Tumor NGS Genetic Testing Introduction
11.4.4 Thermo Fisher Scientific Inc. Revenue in Tumor NGS Genetic Testing Business (2020-2025)
11.4.5 Thermo Fisher Scientific Inc. Recent Development
11.5 DIAN DIAGNOSTICS Group Co., Ltd.
11.5.1 DIAN DIAGNOSTICS Group Co., Ltd. Company Details
11.5.2 DIAN DIAGNOSTICS Group Co., Ltd. Business Overview
11.5.3 DIAN DIAGNOSTICS Group Co., Ltd. Tumor NGS Genetic Testing Introduction
11.5.4 DIAN DIAGNOSTICS Group Co., Ltd. Revenue in Tumor NGS Genetic Testing Business (2020-2025)
11.5.5 DIAN DIAGNOSTICS Group Co., Ltd. Recent Development
11.6 Burning Rock Biotech.
11.6.1 Burning Rock Biotech. Company Details
11.6.2 Burning Rock Biotech. Business Overview
11.6.3 Burning Rock Biotech. Tumor NGS Genetic Testing Introduction
11.6.4 Burning Rock Biotech. Revenue in Tumor NGS Genetic Testing Business (2020-2025)
11.6.5 Burning Rock Biotech. Recent Development
11.7 NovogeneCo.,Ltd.
11.7.1 NovogeneCo.,Ltd. Company Details
11.7.2 NovogeneCo.,Ltd. Business Overview
11.7.3 NovogeneCo.,Ltd. Tumor NGS Genetic Testing Introduction
11.7.4 NovogeneCo.,Ltd. Revenue in Tumor NGS Genetic Testing Business (2020-2025)
11.7.5 NovogeneCo.,Ltd. Recent Development
11.8 Nanjing Shihejiyin Technology, Inc.
11.8.1 Nanjing Shihejiyin Technology, Inc. Company Details
11.8.2 Nanjing Shihejiyin Technology, Inc. Business Overview
11.8.3 Nanjing Shihejiyin Technology, Inc. Tumor NGS Genetic Testing Introduction
11.8.4 Nanjing Shihejiyin Technology, Inc. Revenue in Tumor NGS Genetic Testing Business (2020-2025)
11.8.5 Nanjing Shihejiyin Technology, Inc. Recent Development
11.9 Amoy Diagnostics Co.,Ltd.
11.9.1 Amoy Diagnostics Co.,Ltd. Company Details
11.9.2 Amoy Diagnostics Co.,Ltd. Business Overview
11.9.3 Amoy Diagnostics Co.,Ltd. Tumor NGS Genetic Testing Introduction
11.9.4 Amoy Diagnostics Co.,Ltd. Revenue in Tumor NGS Genetic Testing Business (2020-2025)
11.9.5 Amoy Diagnostics Co.,Ltd. Recent Development
11.10 China National Pharmaceutical Group Corporation
11.10.1 China National Pharmaceutical Group Corporation Company Details
11.10.2 China National Pharmaceutical Group Corporation Business Overview
11.10.3 China National Pharmaceutical Group Corporation Tumor NGS Genetic Testing Introduction
11.10.4 China National Pharmaceutical Group Corporation Revenue in Tumor NGS Genetic Testing Business (2020-2025)
11.10.5 China National Pharmaceutical Group Corporation Recent Development
11.11 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.
11.11.1 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Company Details
11.11.2 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Business Overview
11.11.3 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Tumor NGS Genetic Testing Introduction
11.11.4 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Revenue in Tumor NGS Genetic Testing Business (2020-2025)
11.11.5 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Recent Development
11.12 Guangzhou Kingmed Diagnostics Group Co.,Ltd.
11.12.1 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Company Details
11.12.2 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Business Overview
11.12.3 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Tumor NGS Genetic Testing Introduction
11.12.4 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Revenue in Tumor NGS Genetic Testing Business (2020-2025)
11.12.5 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Recent Development
11.13 ADICON Clinical Laboratories, Inc.
11.13.1 ADICON Clinical Laboratories, Inc. Company Details
11.13.2 ADICON Clinical Laboratories, Inc. Business Overview
11.13.3 ADICON Clinical Laboratories, Inc. Tumor NGS Genetic Testing Introduction
11.13.4 ADICON Clinical Laboratories, Inc. Revenue in Tumor NGS Genetic Testing Business (2020-2025)
11.13.5 ADICON Clinical Laboratories, Inc. Recent Development
11.14 Genetron
11.14.1 Genetron Company Details
11.14.2 Genetron Business Overview
11.14.3 Genetron Tumor NGS Genetic Testing Introduction
11.14.4 Genetron Revenue in Tumor NGS Genetic Testing Business (2020-2025)
11.14.5 Genetron Recent Development
11.15 Genecast Group Inc.
11.15.1 Genecast Group Inc. Company Details
11.15.2 Genecast Group Inc. Business Overview
11.15.3 Genecast Group Inc. Tumor NGS Genetic Testing Introduction
11.15.4 Genecast Group Inc. Revenue in Tumor NGS Genetic Testing Business (2020-2025)
11.15.5 Genecast Group Inc. Recent Development
11.16 BGI Genomics Co.,Ltd.
11.16.1 BGI Genomics Co.,Ltd. Company Details
11.16.2 BGI Genomics Co.,Ltd. Business Overview
11.16.3 BGI Genomics Co.,Ltd. Tumor NGS Genetic Testing Introduction
11.16.4 BGI Genomics Co.,Ltd. Revenue in Tumor NGS Genetic Testing Business (2020-2025)
11.16.5 BGI Genomics Co.,Ltd. Recent Development
11.17 Beijing-Geneplus Technology Limited.
11.17.1 Beijing-Geneplus Technology Limited. Company Details
11.17.2 Beijing-Geneplus Technology Limited. Business Overview
11.17.3 Beijing-Geneplus Technology Limited. Tumor NGS Genetic Testing Introduction
11.17.4 Beijing-Geneplus Technology Limited. Revenue in Tumor NGS Genetic Testing Business (2020-2025)
11.17.5 Beijing-Geneplus Technology Limited. Recent Development
11.18 Xiamen SpacegenCo., Ltd.
11.18.1 Xiamen SpacegenCo., Ltd. Company Details
11.18.2 Xiamen SpacegenCo., Ltd. Business Overview
11.18.3 Xiamen SpacegenCo., Ltd. Tumor NGS Genetic Testing Introduction
11.18.4 Xiamen SpacegenCo., Ltd. Revenue in Tumor NGS Genetic Testing Business (2020-2025)
11.18.5 Xiamen SpacegenCo., Ltd. Recent Development
11.19 Geneis（Beijing）Co.Ltd.
11.19.1 Geneis（Beijing）Co.Ltd. Company Details
11.19.2 Geneis（Beijing）Co.Ltd. Business Overview
11.19.3 Geneis（Beijing）Co.Ltd. Tumor NGS Genetic Testing Introduction
11.19.4 Geneis（Beijing）Co.Ltd. Revenue in Tumor NGS Genetic Testing Business (2020-2025)
11.19.5 Geneis（Beijing）Co.Ltd. Recent Development
11.20 HaploX
11.20.1 HaploX Company Details
11.20.2 HaploX Business Overview
11.20.3 HaploX Tumor NGS Genetic Testing Introduction
11.20.4 HaploX Revenue in Tumor NGS Genetic Testing Business (2020-2025)
11.20.5 HaploX Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Foundation Medicine
Guardant Health
Illumina Inc
Thermo Fisher Scientific Inc
Dian Diagnostics Group Co.,Ltd.
Burning Rock Biotech
NovogeneCo.,Ltd.
Amoy Diagnostics Co.,Ltd.
China National Pharmaceutical Group Corporation
Shanghai Fosun Pharmaceutical (Group) Co. Ltd.
Guangzhou Kingmed Diagnostics Group Co., Ltd.
Adicon Clinical Laboratories Inc.
Genetron
BGI Genomics Co.,Ltd.
Haplox
Nanjing Shihejiyin Technology, Inc.
Genecast Group Inc.
Beijing-Geneplus Technology Limited.
Xiamen SpacegenCo., Ltd.
Geneis（Beijing）Co.Ltd.
List of Tables
 Table 1. Global Tumor NGS Genetic Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Liquid Biopsy (Blood Sample)
 Table 3. Key Players of Tissue Biopsy
 Table 4. Global Tumor NGS Genetic Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Tumor NGS Genetic Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Tumor NGS Genetic Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Tumor NGS Genetic Testing Market Share by Region (2020-2025)
 Table 8. Global Tumor NGS Genetic Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Tumor NGS Genetic Testing Market Share by Region (2026-2031)
 Table 10. Tumor NGS Genetic Testing Market Trends
 Table 11. Tumor NGS Genetic Testing Market Drivers
 Table 12. Tumor NGS Genetic Testing Market Challenges
 Table 13. Tumor NGS Genetic Testing Market Restraints
 Table 14. Global Tumor NGS Genetic Testing Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Tumor NGS Genetic Testing Market Share by Players (2020-2025)
 Table 16. Global Top Tumor NGS Genetic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor NGS Genetic Testing as of 2024)
 Table 17. Ranking of Global Top Tumor NGS Genetic Testing Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Tumor NGS Genetic Testing Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Tumor NGS Genetic Testing, Headquarters and Area Served
 Table 20. Global Key Players of Tumor NGS Genetic Testing, Product and Application
 Table 21. Global Key Players of Tumor NGS Genetic Testing, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Tumor NGS Genetic Testing Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Tumor NGS Genetic Testing Revenue Market Share by Type (2020-2025)
 Table 25. Global Tumor NGS Genetic Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Tumor NGS Genetic Testing Revenue Market Share by Type (2026-2031)
 Table 27. Global Tumor NGS Genetic Testing Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Tumor NGS Genetic Testing Revenue Market Share by Application (2020-2025)
 Table 29. Global Tumor NGS Genetic Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Tumor NGS Genetic Testing Revenue Market Share by Application (2026-2031)
 Table 31. North America Tumor NGS Genetic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Tumor NGS Genetic Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Tumor NGS Genetic Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Tumor NGS Genetic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Tumor NGS Genetic Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Tumor NGS Genetic Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Tumor NGS Genetic Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Tumor NGS Genetic Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Tumor NGS Genetic Testing Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Tumor NGS Genetic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Tumor NGS Genetic Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Tumor NGS Genetic Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Tumor NGS Genetic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Tumor NGS Genetic Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Tumor NGS Genetic Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Foundation Medicine Company Details
 Table 47. Foundation Medicine Business Overview
 Table 48. Foundation Medicine Tumor NGS Genetic Testing Product
 Table 49. Foundation Medicine Revenue in Tumor NGS Genetic Testing Business (2020-2025) & (US$ Million)
 Table 50. Foundation Medicine Recent Development
 Table 51. Guardant Health Company Details
 Table 52. Guardant Health Business Overview
 Table 53. Guardant Health Tumor NGS Genetic Testing Product
 Table 54. Guardant Health Revenue in Tumor NGS Genetic Testing Business (2020-2025) & (US$ Million)
 Table 55. Guardant Health Recent Development
 Table 56. Illumina Company Details
 Table 57. Illumina Business Overview
 Table 58. Illumina Tumor NGS Genetic Testing Product
 Table 59. Illumina Revenue in Tumor NGS Genetic Testing Business (2020-2025) & (US$ Million)
 Table 60. Illumina Recent Development
 Table 61. Thermo Fisher Scientific Inc. Company Details
 Table 62. Thermo Fisher Scientific Inc. Business Overview
 Table 63. Thermo Fisher Scientific Inc. Tumor NGS Genetic Testing Product
 Table 64. Thermo Fisher Scientific Inc. Revenue in Tumor NGS Genetic Testing Business (2020-2025) & (US$ Million)
 Table 65. Thermo Fisher Scientific Inc. Recent Development
 Table 66. DIAN DIAGNOSTICS Group Co., Ltd. Company Details
 Table 67. DIAN DIAGNOSTICS Group Co., Ltd. Business Overview
 Table 68. DIAN DIAGNOSTICS Group Co., Ltd. Tumor NGS Genetic Testing Product
 Table 69. DIAN DIAGNOSTICS Group Co., Ltd. Revenue in Tumor NGS Genetic Testing Business (2020-2025) & (US$ Million)
 Table 70. DIAN DIAGNOSTICS Group Co., Ltd. Recent Development
 Table 71. Burning Rock Biotech. Company Details
 Table 72. Burning Rock Biotech. Business Overview
 Table 73. Burning Rock Biotech. Tumor NGS Genetic Testing Product
 Table 74. Burning Rock Biotech. Revenue in Tumor NGS Genetic Testing Business (2020-2025) & (US$ Million)
 Table 75. Burning Rock Biotech. Recent Development
 Table 76. NovogeneCo.,Ltd. Company Details
 Table 77. NovogeneCo.,Ltd. Business Overview
 Table 78. NovogeneCo.,Ltd. Tumor NGS Genetic Testing Product
 Table 79. NovogeneCo.,Ltd. Revenue in Tumor NGS Genetic Testing Business (2020-2025) & (US$ Million)
 Table 80. NovogeneCo.,Ltd. Recent Development
 Table 81. Nanjing Shihejiyin Technology, Inc. Company Details
 Table 82. Nanjing Shihejiyin Technology, Inc. Business Overview
 Table 83. Nanjing Shihejiyin Technology, Inc. Tumor NGS Genetic Testing Product
 Table 84. Nanjing Shihejiyin Technology, Inc. Revenue in Tumor NGS Genetic Testing Business (2020-2025) & (US$ Million)
 Table 85. Nanjing Shihejiyin Technology, Inc. Recent Development
 Table 86. Amoy Diagnostics Co.,Ltd. Company Details
 Table 87. Amoy Diagnostics Co.,Ltd. Business Overview
 Table 88. Amoy Diagnostics Co.,Ltd. Tumor NGS Genetic Testing Product
 Table 89. Amoy Diagnostics Co.,Ltd. Revenue in Tumor NGS Genetic Testing Business (2020-2025) & (US$ Million)
 Table 90. Amoy Diagnostics Co.,Ltd. Recent Development
 Table 91. China National Pharmaceutical Group Corporation Company Details
 Table 92. China National Pharmaceutical Group Corporation Business Overview
 Table 93. China National Pharmaceutical Group Corporation Tumor NGS Genetic Testing Product
 Table 94. China National Pharmaceutical Group Corporation Revenue in Tumor NGS Genetic Testing Business (2020-2025) & (US$ Million)
 Table 95. China National Pharmaceutical Group Corporation Recent Development
 Table 96. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Company Details
 Table 97. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Business Overview
 Table 98. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Tumor NGS Genetic Testing Product
 Table 99. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Revenue in Tumor NGS Genetic Testing Business (2020-2025) & (US$ Million)
 Table 100. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Recent Development
 Table 101. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Company Details
 Table 102. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Business Overview
 Table 103. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Tumor NGS Genetic Testing Product
 Table 104. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Revenue in Tumor NGS Genetic Testing Business (2020-2025) & (US$ Million)
 Table 105. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Recent Development
 Table 106. ADICON Clinical Laboratories, Inc. Company Details
 Table 107. ADICON Clinical Laboratories, Inc. Business Overview
 Table 108. ADICON Clinical Laboratories, Inc. Tumor NGS Genetic Testing Product
 Table 109. ADICON Clinical Laboratories, Inc. Revenue in Tumor NGS Genetic Testing Business (2020-2025) & (US$ Million)
 Table 110. ADICON Clinical Laboratories, Inc. Recent Development
 Table 111. Genetron Company Details
 Table 112. Genetron Business Overview
 Table 113. Genetron Tumor NGS Genetic Testing Product
 Table 114. Genetron Revenue in Tumor NGS Genetic Testing Business (2020-2025) & (US$ Million)
 Table 115. Genetron Recent Development
 Table 116. Genecast Group Inc. Company Details
 Table 117. Genecast Group Inc. Business Overview
 Table 118. Genecast Group Inc. Tumor NGS Genetic Testing Product
 Table 119. Genecast Group Inc. Revenue in Tumor NGS Genetic Testing Business (2020-2025) & (US$ Million)
 Table 120. Genecast Group Inc. Recent Development
 Table 121. BGI Genomics Co.,Ltd. Company Details
 Table 122. BGI Genomics Co.,Ltd. Business Overview
 Table 123. BGI Genomics Co.,Ltd. Tumor NGS Genetic Testing Product
 Table 124. BGI Genomics Co.,Ltd. Revenue in Tumor NGS Genetic Testing Business (2020-2025) & (US$ Million)
 Table 125. BGI Genomics Co.,Ltd. Recent Development
 Table 126. Beijing-Geneplus Technology Limited. Company Details
 Table 127. Beijing-Geneplus Technology Limited. Business Overview
 Table 128. Beijing-Geneplus Technology Limited. Tumor NGS Genetic Testing Product
 Table 129. Beijing-Geneplus Technology Limited. Revenue in Tumor NGS Genetic Testing Business (2020-2025) & (US$ Million)
 Table 130. Beijing-Geneplus Technology Limited. Recent Development
 Table 131. Xiamen SpacegenCo., Ltd. Company Details
 Table 132. Xiamen SpacegenCo., Ltd. Business Overview
 Table 133. Xiamen SpacegenCo., Ltd. Tumor NGS Genetic Testing Product
 Table 134. Xiamen SpacegenCo., Ltd. Revenue in Tumor NGS Genetic Testing Business (2020-2025) & (US$ Million)
 Table 135. Xiamen SpacegenCo., Ltd. Recent Development
 Table 136. Geneis（Beijing）Co.Ltd. Company Details
 Table 137. Geneis（Beijing）Co.Ltd. Business Overview
 Table 138. Geneis（Beijing）Co.Ltd. Tumor NGS Genetic Testing Product
 Table 139. Geneis（Beijing）Co.Ltd. Revenue in Tumor NGS Genetic Testing Business (2020-2025) & (US$ Million)
 Table 140. Geneis（Beijing）Co.Ltd. Recent Development
 Table 141. HaploX Company Details
 Table 142. HaploX Business Overview
 Table 143. HaploX Tumor NGS Genetic Testing Product
 Table 144. HaploX Revenue in Tumor NGS Genetic Testing Business (2020-2025) & (US$ Million)
 Table 145. HaploX Recent Development
 Table 146. Research Programs/Design for This Report
 Table 147. Key Data Information from Secondary Sources
 Table 148. Key Data Information from Primary Sources
 Table 149. Authors List of This Report


List of Figures
 Figure 1. Tumor NGS Genetic Testing Picture
 Figure 2. Global Tumor NGS Genetic Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Tumor NGS Genetic Testing Market Share by Type: 2024 VS 2031
 Figure 4. Liquid Biopsy (Blood Sample) Features
 Figure 5. Tissue Biopsy Features
 Figure 6. Global Tumor NGS Genetic Testing Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Tumor NGS Genetic Testing Market Share by Application: 2024 VS 2031
 Figure 8. Companion Diagnostics Case Studies
 Figure 9. Early Cancer Screening Case Studies
 Figure 10. Drug Discovery Case Studies
 Figure 11. Tumor NGS Genetic Testing Report Years Considered
 Figure 12. Global Tumor NGS Genetic Testing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Tumor NGS Genetic Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Tumor NGS Genetic Testing Market Share by Region: 2024 VS 2031
 Figure 15. Global Tumor NGS Genetic Testing Market Share by Players in 2024
 Figure 16. Global Top Tumor NGS Genetic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor NGS Genetic Testing as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Tumor NGS Genetic Testing Revenue in 2024
 Figure 18. North America Tumor NGS Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Tumor NGS Genetic Testing Market Share by Country (2020-2031)
 Figure 20. United States Tumor NGS Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Tumor NGS Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Tumor NGS Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Tumor NGS Genetic Testing Market Share by Country (2020-2031)
 Figure 24. Germany Tumor NGS Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Tumor NGS Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Tumor NGS Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Tumor NGS Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Tumor NGS Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Tumor NGS Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Tumor NGS Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Tumor NGS Genetic Testing Market Share by Region (2020-2031)
 Figure 32. China Tumor NGS Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Tumor NGS Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Tumor NGS Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Tumor NGS Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Tumor NGS Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Tumor NGS Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Tumor NGS Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Tumor NGS Genetic Testing Market Share by Country (2020-2031)
 Figure 40. Mexico Tumor NGS Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Tumor NGS Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Tumor NGS Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Tumor NGS Genetic Testing Market Share by Country (2020-2031)
 Figure 44. Turkey Tumor NGS Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Tumor NGS Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Tumor NGS Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Foundation Medicine Revenue Growth Rate in Tumor NGS Genetic Testing Business (2020-2025)
 Figure 48. Guardant Health Revenue Growth Rate in Tumor NGS Genetic Testing Business (2020-2025)
 Figure 49. Illumina Revenue Growth Rate in Tumor NGS Genetic Testing Business (2020-2025)
 Figure 50. Thermo Fisher Scientific Inc. Revenue Growth Rate in Tumor NGS Genetic Testing Business (2020-2025)
 Figure 51. DIAN DIAGNOSTICS Group Co., Ltd. Revenue Growth Rate in Tumor NGS Genetic Testing Business (2020-2025)
 Figure 52. Burning Rock Biotech. Revenue Growth Rate in Tumor NGS Genetic Testing Business (2020-2025)
 Figure 53. NovogeneCo.,Ltd. Revenue Growth Rate in Tumor NGS Genetic Testing Business (2020-2025)
 Figure 54. Nanjing Shihejiyin Technology, Inc. Revenue Growth Rate in Tumor NGS Genetic Testing Business (2020-2025)
 Figure 55. Amoy Diagnostics Co.,Ltd. Revenue Growth Rate in Tumor NGS Genetic Testing Business (2020-2025)
 Figure 56. China National Pharmaceutical Group Corporation Revenue Growth Rate in Tumor NGS Genetic Testing Business (2020-2025)
 Figure 57. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Revenue Growth Rate in Tumor NGS Genetic Testing Business (2020-2025)
 Figure 58. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Revenue Growth Rate in Tumor NGS Genetic Testing Business (2020-2025)
 Figure 59. ADICON Clinical Laboratories, Inc. Revenue Growth Rate in Tumor NGS Genetic Testing Business (2020-2025)
 Figure 60. Genetron Revenue Growth Rate in Tumor NGS Genetic Testing Business (2020-2025)
 Figure 61. Genecast Group Inc. Revenue Growth Rate in Tumor NGS Genetic Testing Business (2020-2025)
 Figure 62. BGI Genomics Co.,Ltd. Revenue Growth Rate in Tumor NGS Genetic Testing Business (2020-2025)
 Figure 63. Beijing-Geneplus Technology Limited. Revenue Growth Rate in Tumor NGS Genetic Testing Business (2020-2025)
 Figure 64. Xiamen SpacegenCo., Ltd. Revenue Growth Rate in Tumor NGS Genetic Testing Business (2020-2025)
 Figure 65. Geneis（Beijing）Co.Ltd. Revenue Growth Rate in Tumor NGS Genetic Testing Business (2020-2025)
 Figure 66. HaploX Revenue Growth Rate in Tumor NGS Genetic Testing Business (2020-2025)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Next Generation Tumor Genetic Testing Market Research Report 2024
Global Tumor Genomics Market Research Report 2024
Genetic Testing for Cancer Risk Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Next Generation Sequencing NGS Services Market Research Report 2024
Global High Throughput Sequencing NGS Market Research Report 2024
Global Clinical Oncology Next Generation Sequencing Market Research Report 2024
Global Next Generation Sequencing Technology Market Research Report 2025
Global Clinical Next Generation Sequencing Market Insights Forecast to 2030
Global Next Generation Sequencing Market Research Report 2025
Global Genomic Testing in Cancer Market Research Report 2024
Next Generation Sequencing NGS Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
dna next generation sequencing market
Global Cancer Genomic Testing Market Research Report 2024
Global Tumor Gene Test Service Market Research Report 2025
Global Precision Cancer Tests Market Research Report 2024
Global Next Generation Sequencing Data Analysis Market Research Report 2024
Global Tumor Marker Testing Market Research Report 2024
Next Generation Sequencing NGS Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
NGS Based Monitoring and Diagnostic Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
NGS Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions